Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Maxcyte (MXCT) Inventory Average (2021 - 2026)

Maxcyte has reported Inventory Average over the past 5 years, most recently at $7.6 million for Q4 2025.

  • Quarterly Inventory Average fell 21.49% to $7.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.6 million through Dec 2025, down 21.49% year-over-year, with the annual reading at $8.2 million for FY2025, 22.14% down from the prior year.
  • Inventory Average was $7.6 million for Q4 2025 at Maxcyte, down from $7.8 million in the prior quarter.
  • Over five years, Inventory Average peaked at $12.4 million in Q4 2023 and troughed at $4.2 million in Q3 2021.
  • The 5-year median for Inventory Average is $8.4 million (2022), against an average of $8.8 million.
  • Year-over-year, Inventory Average soared 87.95% in 2022 and then decreased 29.9% in 2025.
  • A 5-year view of Inventory Average shows it stood at $4.7 million in 2021, then soared by 76.33% to $8.2 million in 2022, then skyrocketed by 50.14% to $12.4 million in 2023, then decreased by 22.03% to $9.7 million in 2024, then dropped by 21.49% to $7.6 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Inventory Average are $7.6 million (Q4 2025), $7.8 million (Q3 2025), and $8.1 million (Q2 2025).